netFormulary
 Report : A-Z of formulary items 26/09/2020 02:08:32
[Back]
 
Section Name Details
05.03.01 Abacavir Ziagen®
05.03.01 Abacavir and Lamivudine Kivexa®
05.03.01 Abacavir and Lamivudine and Zidovudine Trizivir®
10.01.03 Abatacept Orencia®
02.09 Abciximab 
08.01.05 Abemaciclib verzenios ®
08.03.04.02 Abiraterone Zytiga®
08.01.05 Acalabrutinib Calquence®

Not yet commmissioned by NHSE 

04.10.01 Acamprosate Campral EC®
06.01.02.03 Acarbose Glucobay®
02.08.02 Acenocoumarol Sinthrome®

Restricted Item Information on restriction; only for use in patients allergic to warfarin

11.06 Acetazolamide Diamox®
11.08.02 Acetylcholine Chloride Miochol-E®
11.08.01 Acetylcysteine 
05.03.02.01 Aciclovir Zovirax®
13.10.03 Aciclovir Zovirax®
11.03.03 Aciclovir eye ointment 3% Zovirax®

Aciclovir eye ointment to be discontinued June 2019.

Use Ganciclovir instead

13.05.02 Acitretin Neotigason®
01.05.03 Adalimumab 
10.01.03 Adalimumab Humira®
13.05.03 Adalimumab Humira®
13.06.01 Adapalene Differin®
05.03.03.01 Adefovir Dipivoxil Hepsera®
02.03.02 Adenosine Adenocor®
03.04.03 Adrenaline / epinephrine 1 in 1,000 
02.07.03 Adrenaline / Epinephrine 1 in 10,000 (dilute) 
03.04.03 Adrenaline / epinephrine 1 in 10,000 (dilute) 
08.01.05 Afatinib Giotrif®
08.01.05 Aflibercept Zaltrap®
11.08.02 Aflibercept Eylea®
09.02.02.02 Albumin Solution 
13.11.01 Alcohol 
08.01.05 Alectinib Alecensa®
08.02.03 Alemtuzumab MabCampath®
06.06.02 Alendronic Acid 
09.06.04 Alfacalcidol One-Alpha®
15.01.04.03 Alfentanil Rapifen®
03.04.01 Alimemazine Vallergan®
02.05.05.03 Aliskiren Rasilez®
13.05.01 Alitretinoin Toctino®
10.01.04 Allopurinol 
06.01.02.03 Alogliptin Vipidia▼®
09.06.05 Alpha Tocopheryl Acetate 

Vitamin E oral suspension 

09.06.05 Alpha Tocopheryl Acetate (INJECTION) 

Restricted Item Information on restriction

Injection restricted to use by Paediatrics for chronic liver disease with inadequate response to oral treatment.

07.04.05 Alprostadil Caverject®
02.10.02 Alteplase Actilyse®
13.12 Aluminimum Salts 
01.02 Alverine citrate 
04.09.01 Amantadine 
05.03.04 Amantadine Hydrochloride Symmetrel®
05.01.04 Amikacin 
02.02.03 Amiloride Hydrochloride 
03.01.03 Aminophylline Phyllocontin Continus®
03.01.03 Aminophylline IV 
02.03.02 Amiodarone 
04.02.01 Amisulpride 
04.03.01 Amitriptyline 
02.06.02 Amlodipine 
05.01.01.03 Amoxicillin 
05.02 Amphotericin Fungizone®
05.01.01.03 Ampicillin 
09.01.04 Anagrelide Xagrid®
08.03.04.01 Anastrozole 
05.02.04 Anidulafungin Ecalta®
12.03.01 Antacid with Oxetacaine 

Restricted Item Information on restriction 

Restricted to oncology / haematology use only

11.04.02 Antazoline 0.5% with Xylometazoline 0.05% Otrivine-Antistin®
02.08.02 Apixaban Eliquis®
04.09.01 Apomorphine 

note  Note

First line - Dacepton 

Second line - Apo-go ; for existing patients and on occaisions when Dacepton isn’t suitable

 

 

11.08.02 Apraclonidine Iopidine®
04.06 Aprepitant Emend®
13.02.01 Aquadrate ® 
01.06.03 Arachis Oil 
02.08.01 Argatroban Exembol®
04.02.01 Aripiprazole 
12.03.05 AS saliva Orthana ® 
09.06.03 Ascorbic Acid Vitamin C
04.02.03 Asenapine 
09.08.01 Asfotase alfa Strensiq®
04.07.01 Aspirin 

Dispersible should be used. 

E/C preparations are non-formulary

02.09 Aspirin (antiplatelet) 

Dispersible should be used. 

E/C preparations are non-formulary

05.03.01 Atazanavir Reyataz®
05.03.01 Atazanavir + Cobicistat Evotaz®
02.04 Atenolol 
08.01.05 Atezolizumab Tecentriq®
04.04 Atomoxetine Strattera®
02.12 Atorvastatin 
07.01.03 Atosiban 
15.01.05 Atracurium Besilate Tracrium®
11.05 Atropine 
15.01.03 Atropine  
11.05 Atropine Sulphate single use Minims® Atropine Sulphate
08.01.05 Avelumab 

As per MMC meeting September 2020

08.01.05 Axitinib Inlyta®
08.01.03 Azacitidine Vidaza®
01.05.03 Azathioprine 
08.02.01 Azathioprine 
10.01.03 Azathioprine 
13.05.03 Azathioprine 
13.06.01 Azelaic Acid Skinoren®
11.04.02 Azelastine Optilast®
05.01.05 Azithromycin 
11.03.01 Azithromycin Azyter®

Restricted Item Information on restriction

The use of this product is for the management of blepharokeratoconjunctivitis
in paediatric practice.

With a therapy course of twice a day for 3 days, repeated 3 times in the first month, twice in the second month and once in the third month.

Not for use in Adults 

05.01.02.03 Aztreonam Azactam®
10.02.02 Baclofen 
01.05.01 Balsalazide 
13.02.02 Barrier preparation Metanium®
13.02.02 Barrier preparation Siopel®
13.02.02 Barrier preparation Sudocrem®
08.02.04 BCG bladder instillation ImmuCyst®
03.02 Beclometasone 
03.02 Beclometasone Qvar®
03.02 Beclometasone and formoterol Fostair®
12.02.01 Beclometasone Dipropionate Beconase®
03.01.04 beclometasone dipropionate/formoterol fumarate dihydrate/glycopyrronium bromide Trimbow ®
08.01.01 Bendamustine 
02.02.01 Bendroflumethiazide 
20 Benzbromarone 

unlicensed unlicensed

 

Restricted Item Information on restriction

Restricted to patients who are unable to take allopurinol or febuxostat who have mild renal impairment.

Specialist use only. 

 

13.06.01 Benzoyl Peroxide 5% with Clindamycin 1% Duac® Once Daily
12.03.01 Benzydamine Difflam®
05.01.01.01 Benzylpenicillin Crystapen®
05.01.01.01 Benzylpenicillin Benzathine 
04.06 Betahistine Dihydrochloride 
06.03.02 Betamethasone Betnesol®
12.03.01 Betamethasone 
13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic®
13.04 Betamethasone (as Valerate) 0.025% Betnovate-RD®
13.04 Betamethasone (as Valerate) 0.1% Betnovate®
13.04 Betamethasone (as Valerate) 0.1% with Clioquinol 
13.04 Betamethasone (as Valerate) 0.1% with Neomycin Sulphate 0.5% was Betnovate-N®
12.01.01 Betamethasone 0.1% with Neomycin 0.5% ear drops Betnesol N®
11.04.01 Betamethasone 0.1% with Neomycin 0.5% eye drops Betnesol N®
13.04 Betamethasone Dipropionate 0.064% with Clotrimazole 1% Lotriderm®
12.01.01 Betamethasone ear drops 
13.04 Betamethasone Esters Betacap®
11.04.01 Betamethasone eye drops 
12.02.01 Betamethasone Sodium Phosphate Betnesol®
12.02.01 Betamethasone Sodium Phosphate Vista-Methasone®
12.02.03 Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5% 
08.01.05 Bevacizumab Avastin®
02.12 Bezafibrate Bezalip®
02.12 Bezafibrate 
02.12 Bezafibrate Bezalip® Mono
08.03.04.02 Bicalutamide 
11.06 Bimatoprost Lumigan®
11.06 Bimatoprost with Timolol Ganfort®
12.03.05 BioXtra ® 
06.01.01.02 Biphasic Insulin Aspart NovoMix® 30
06.01.01.02 Biphasic Insulin Lispro Humalog® Mix
06.01.01.02 Biphasic Isophane Insulin Hypurin® Porcine 30/70 Mix
06.01.01.02 Biphasic Isophane Insulin Insuman® Comb
06.01.01.02 Biphasic Isophane Insulin Humulin® M3
01.06.02 Bisacodyl 
01.03.03 Bismuth subsalicylate Pepto-Bismol®

This is restricted to use in H. Pylori eradication as per NICE guidelines 

NICE CG184

02.04 Bisoprolol 
08.01.02 Bleomycin 
06.01.06 Blood Glucose Meters 
05.03.03.02 Boceprevir Victrelis®
08.01.05 Bortezomib Velcade®
08.01.05 Bosutinib Bosulif®
04.09.03 Botulinum A toxin Botox®
08.01.05 Brentuximab vedotin Adcetris®
11.06 Brimonidine Tartrate Alphagan®
11.06 Brimonidine Tartrate 0.2% with Timolol 0.5% Combigan®
11.06 Brinzolamide Azopt®
11.06 Brinzolamide 1% with Timolol 0.5%  Azarga®
11.06 Brinzolamide 10mg/ml & brimonidine 2mg/ml Simbrinza®
04.08.01 Brivaracetam Briviact®

Restricted to specialist use only - Neurology 

Green Green Specialist initiation

Notes: 

As an adjunctive third line treatment option for the management of partial-onset seizures with or without secondary generalisation in adults. Brivaracetam may be considered if there is:

  • failure of one or more first line drugs (carbamazepine, lamotrigine or levetiracetam) AND
  • failure of one or more 2nd line drugs (topiramate, pregabalin, lacosamide, zonisamide or perampanel
  • for patients who had an effective antiepileptic response to leviteracetam but suffered poor mood issues on it and other treatments have not been effective or have been problematic.

 

13.05 Brodalumab 

Approved for use in line with pathway moderate to severe plaque psoriasis 

11.08.02 Bromfenac Yellox®

To be used instead of Ketorolac due to ketorolac being unavailable

04.09.01 Bromocriptine 
06.07.01 Bromocriptine Parlodel®
01.05.02 Budesonide 

Budenofalk enema available on formulary. This replaces Predfoam enema. 

Budesonide MR (Cortiment) in adults for induction of remission for mild to moderate ulcerative colitis where aminosalicylate treatment not sufficient. 

 

Red 
The use of orodispersible budesonide for treatment of eosinophilic esophagitis (EoE) in adults (older than 18 years) is a RED indication and should be prescribed by secondary care only.

03.02 Budesonide and formoterol Symbicort®
02.02.02 Bumetanide 
15.02 Bupivacaine Hydrochloride 
04.07.02 Buprenorphine Temgesic®
04.07.02 Buprenorphine Transtec® patch
04.07.02 Buprenorphine BuTrans® patch
04.10.03 Buprenorphine Subutex®
04.10.02 Bupropion Hydrochloride Zyban®
06.07.02 Buserelin 
08.01.01 Busulfan 
08.01.05 Cabazitaxel Jevtana®
04.09.01 Cabergoline 
06.07.01 Cabergoline 
13.03 Calamine 
13.05.02 Calcipotriol 
13.05.02 Calcipotriol 50micrograms/g with Betamethasone 0.05% 

Dovobet 50 microgram/g + 0.5 mg/g ointment is formulary 

Dovobet 50 microgram/g + 0.5 mg/g gel is formulary 

 

Restricted Item Enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam – restricted to initiation by Dermatologists

09.06.04 Calcitriol 
13.05.02 Calcitriol 3micrograms/g Silkis®
09.05.01.01 Calcium carbonate 
09.06.04 Calcium Carbonate with Colecalciferol 
09.05.01.01 Calcium Chloride 
08.01 Calcium Folinate 
09.05.01.01 Calcium Gluconate 
06.01.02.03 Canagliflozin Invokana▼®
02.05.05.02 Candesartan 
04.08.01 Cannabidiol Epidyolex®

Restricted for use as per NICE TA614 & NICE TA615

13.09 Capasal ® 
08.01.03 Capecitabine Xeloda®
12.03.01 Caphosol ® 
10.03.02 Capsaicin 

Capsaicin 0.025% w/w

For the symptomatic relief of pain associated with osteoarthritis.

10.03.02 Capsaicin Axsain ®

Capsaicin 0.075% w/w

  • For the symptomatic relief of neuralgia associated with and following Herpes Zoster infections (post-herpetic neuralgia) after open skin lesions have healed.
  • For the symptomatic management of painful diabetic peripheral polyneuropathy.
02.05.05.01 Captopril 
04.02.03 Carbamazepine 
04.08.01 Carbamazepine 
06.02.02 Carbimazole Neo-Mercazole®
03.07 Carbocisteine 
11.08.01 Carbomers 
08.01.05 Carboplatin 
07.01.01 Carboprost Hemabate®
11.08.01 Carmellose 
02.04 Carvedilol 
05.02.04 Caspofungin Cancidas®
08.02.04 Cediranib Recentin®
05.01.02 Cefalexin Keflex®
05.01.02.01 Cefixime Suprax®
05.01.02.01 Cefotaxime 
05.01.02.01 Ceftazidime 
05.01.02.03 Ceftazidime/ avibactam Zavicefta®
05.01.02.01 Ceftriaxone 
05.01.02.01 Cefuroxime 
10.01.01 Celecoxib Celebrex®
08.01.05 Ceritinib Zykadia
10.01.03 Certolizumab Pegol Cimzia®
03.04.01 Cetirizine 
13.02.01 Cetraben ® 
13.11.03 Cetrimide 
06.07.02 Cetrorelix Cetrotide®
08.01.05 Cetuximab Erbitux®
04.01.01 Chloral Betaine Welldorm®
04.01.01 Chloral Hydrate 
08.01.01 Chlorambucil 
05.01.07 Chloramphenicol 
11.03.01 Chloramphenicol 
12.01.01 Chloramphenicol 
04.01.02 Chlordiazepoxide 
13.11.02 Chlorhexidine 4% 
12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin®
12.03.04 Chlorhexidine mouthwash 
05.04.01 Chloroquine 
10.01.03 Chloroquine 
03.04.01 Chlorphenamine 
04.02.01 Chlorpromazine 
12.03.01 Choline Salicylate Bonjela® Adult
06.05.01 Choriogonadotropin Alfa Ovitrelle®
06.05.01 Chorionic Gonadotrophin Pregnyl®
03.02 Ciclesonide Alvesco®
01.05.03 Ciclosporin 
08.02.02 Ciclosporin 
10.01.03 Ciclosporin 
11.99.99.99 Ciclosporin 

Ciclosporin 1mg/ml eye drops (Ikervis) Green SI Specialist initiation

Can be used as per NICE TA369 for persistent dry eye - Click Here 

 

Ciclosporin 0.2% eye ointment (Optimmune) unlicensed unlicensed Red

Should only be used in patients who cannot tolerate the licensed eye drops or for patients who the NICE TA369 does not apply to 

13.05.03 Ciclosporin 
01.03.01 Cimetidine 
09.05.01.02 Cinacalcet Mimpara®
04.06 Cinnarizine 
05.01.12 Ciprofloxacin 
08.01.05 Cisplatin 
04.03.03 Citalopram 
01.06.05 Citrafleet ® 
08.01.03 Cladribine 
08.01.03 Cladribine Litak®
05.01.05 Clarithromycin 
05.01.06 Clindamycin 
07.02.02 Clindamycin Dalacin®
13.06.01 Clindamycin 1% Dalacin T®
04.08.01 Clobazam 
13.04 Clobetasol Propionate 0.05% Dermovate®
13.04 Clobetasone Butyrate 0.05% Eumovate®
04.01.01 Clomethiazole Heminevrin®
06.05.01 Clomifene Citrate Clomid®
04.08.01 Clonazepam 
02.05.02 Clonidine Catapres®
02.09 Clopidogrel 
02.09 Clopidogrel 300mg Plavix®
07.02.02 Clotrimazole 
13.10.02 Clotrimazole 
04.02.01 Clozapine Clozaril®
13.09 Coal Tar Extract 5% (Alcoholic) Alphosyl 2 in 1®
13.05.02 Coal tar lotion 5% Exorex®
13.05.02 Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqiud Paraffin 35% Polytar Emollient®
02.02.04 Co-amilofruse (furosemide and amiloride) 
05.01.01.03 Co-Amoxiclav 
04.09.01 Co-Beneldopa Madopar®CR
04.09.01 Co-Beneldopa Madopar®
04.09.01 Co-Careldopa Sinemet® CR
04.09.01 Co-Careldopa Sinemet®
04.09.01 Co-Careldopa Half Sinemet ®CR
04.09.01 Co-Careldopa and Entacapone 
13.06.02 Co-Cyprindiol 
01.06.02 Co-danthramer 
01.06.02 Co-danthrusate 
01.04.02 Codeine 
04.07.02 Codeine 
03.09.01 Codeine Linctus BP 
04.07.02 Codeine Phosphate 
05.01.01.03 Co-Fluampicil 
10.01.04 Colchicine 

Colchicine (Differrent indications and its uses)

LICENSED

  • Acute Gout: 500 micrograms 2–4 times a day until symptoms relieved maximum 6 mg per course, do not repeat course within 3 days.
  • Short-term prophylaxis during initial therapy with allopurinol and uricosuric drugs: 500 micrograms twice daily

UNLICENSED

  • Acute Pericarditis:  >70kg: 0.5 mg PO twice daily for 3 months, 

    ≤ 70 kg: 0.5 mg PO once daily for 3 months; administer concomitantly with standard anti-inflammatory therapy for acute pericarditis (study dose)

  • Multiple recurrences of Pericarditis: >70 kg: 0.5 mg orally twice daily for 6 months, 

     ≤70 kg or less or intolerant of higher doses: 0.5 mg orally once daily for 6 months. 

    Administer concomitantly with standard anti-inflammatory therapy.
  • Familial Mediterranean fever:  Initially, 1.2mg to 2.4 mg PO daily (can be given in two divided doses); titration, increase or decrease in increments of 0.3 mg/day (FDA dosage).

    Initially, 1mg to 1.8 mg PO daily; in patients with pre-existing conditions (e.g., amyloidosis) or higher disease activity, higher initial doses may be required; titration, if inflammation persists, increase by 0.6 mg/day up to a maximum of 3 mg/day or highest tolerated dose.

  • Prophylaxis of familial Mediterranean fever (recurrent polyserositis):  0.5–2 mg once daily.

  • Post-Pericardiotomy syndrome; Prophylaxis: 

    ≤70kg or intolerant of higher doses: 0.5 mg ORALLY once daily beginning 48 or 72 hours prior to surgery OR on postoperative day 3; continue for 1month post-surgery.

     >70kg: 0.5 mg ORALLY twice daily beginning 48 or 72 hours prior to surgery OR on postoperative day 3; continue for 1 month post-surgery .

    Administer concomitantly with standard anti-inflammatory therapy.
  • Behcet's syndrome: 1 to 1.8 milligrams daily in two or three divided doses.

  • Amyloidosis: Usual dose:  0.5 to 0.6 milligram once daily.

    Maximum dose, 2 milligrams daily in divided doses.

References

  • BNF
  • SPC
  • Micromedex
  • ESC (European society of cardiology guidelines)
09.06.04 Colecalciferol 
02.12 Colesevelam Cholestagel®

AS PER MMC 12.03.20

02.12 Colestipol Colestid®
02.12 Colestyramine 
02.12 Colestyramine Questran®
02.12 Colestyramine Questran® Light
01.09.02 Colestyramine powder 
05.01.07 Colistimethate 
13.10.05 Collodion Flexible BP 
06.04.01.01 Combined continuous HRT tablet Kliofem, Kliovance, Femoston Conti, Premique
06.04.01.01 Combined cyclical HRT tablet Elleste-Duet®, Femoston, Prempak-C
07.03.01 Combined Hormonal Contraceptives Levest®
07.03.01 Combined Hormonal Contraceptives Evra
05.01.08 Co-trimoxazole 
08.01.05 Crizotinib Xalkori®
13.03 Crotamiton Eurax®
09.01.02 Cyanocobalamin 

Restricted Item Information on restriction 

Restricted to oncology / haematology / renal use only

 

During the COVID-19 pandemic cyanocobalamin can use used in other specialities instead of hydroxocobalamin as per the Britsh society for haematology. 

Click here for the guidance - CLICK HERE

04.06 Cyclizine Valoid®
11.05 Cyclopentolate  
11.05 Cyclopentolate Hydrochloride single use Minims® Cyclopentolate Hydrochloride
08.01.01 Cyclophosphamide 
08.03.04.02 Cyproterone 
06.04.02 Cyproterone Acetate Androcur®
08.01.03 Cytarabine 
02.08.02 Dabigatran Pradaxa®
08.01.05 Dacarbazine 
05.01.07 Dalbavancin 

Restricted Item Information on restriction

Resticted to specialist use - Indication ; acute bacterial skin and skin structure infections.

02.08.01 Dalteparin 
02.08.01 Danaparoid Orgaran®
06.07.02 Danazol 
10.02.02 Dantrolene 
15.01.08 Dantrolene Sodium Dantrium Intravenous®
01.06.02 Dantron 
06.01.02.03 Dapagliflozin Forxiga▼®
05.01.10 Dapsone 

Restricted Item Information on restriction

Restricted to Consultant Dermatologist recommendation and PCP prophylaxis in patients allergic to co-trimoxazole

05.01.07 Daptomycin Cubicin®
08.01.05 Daratumumab Darzalex®
09.01.03 Darbepoetin Alfa Aranesp®
07.04.02 Darifenacin Emselex®
08.03.04.02 Darolutamide Nubeqa®

NHSE once comissioned via NICE TA

As per MMC September 2020

05.03.01 Darunavir Prezista®
05.03.01 Darunavir and Cobicistat Rezolsta®
08.01.05 Dasatinib Sprycel®
08.01.02 Daunorubicin 
09.01.03 Deferasirox Exjade®
09.01.03 Deferiprone Ferriprox®
08.03.04.02 Degarelix Firmagon®
06.06.02 Denosumab Prolia®
09.01.03 Desferrioxamine Mesilate Desferal®
15.01.02 Desflurane Suprane®
06.05.02 Desmopressin 
06.05.02 Desmopressin DDAVP®
06.05.02 Desmopressin Desmotabs®
06.05.02 Desmopressin DesmoMelt®
06.05.02 Desmopressin Desmospray®
06.05.02 Desmopressin Octim®
07.03.02.01 Desogestrel Cerazette®, Cerelle®
06.03.02 Dexamethasone 
11.04.01 Dexamethasone eye drops Maxidex®
11.04.01 Dexamethasone eye drops single use 
11.04.01 Dexamethasone intravitreal implant Ozurdex®

Please discuss with pharmacy if you wish to prescribe this due to ongoing supply issue. 

12.01.01 Dexamethasone with Antibacterial Otomize®
12.01.01 Dexamethasone with Antibacterials (ear) Sofradex®
11.04.01 Dexamethasone with Neomycin and Polymyxin B sulphate Maxitrol®
08.01 Dexrazoxane Savene®

For patient under <25 years old

09.02.02.02 Dextran 70 ® 
04.07.02 Diamorphine 
04.01.02 Diazepam 
04.08.02 Diazepam epilepsy
04.08.03 Diazepam 
10.02.02 Diazepam 
15.01.04.01 Diazepam 
06.01.04 Diazoxide 
10.01.01 Diclofenac 

Injection

supporitories

Topical gel

(not available for oral use - instead use ibuprofen or naproxen)

10.03.02 Diclofenac 

Topical gel available on formulary

11.08.02 Diclofenac Voltarol® Ophtha
13.08.01 Diclofenac Solaraze®
11.08.02 Diclofenac Sodium Voltarol® Ophtha multidose
01.02 Dicycloverine 
05.03.01 Didanosine Videx®
08.03.01 Diethylstilbestrol 
02.01.01 Digoxin 
02.01.01 Digoxin specific antibody fragments Digifab®
04.07.02 Dihydrocodeine 

Restricted to breastfeeding mothers and paediatrics

02.06.02 Diltiazem 
01.07.04 Diltiazem Cream 2% 
02.06.02 Diltiazem Hydrochloride Angitil® SR
02.06.02 Diltiazem Hydrochloride Dilzem® SR
02.06.02 Diltiazem Hydrochloride Slozem®
02.06.02 Diltiazem Hydrochloride Tildem® Retard
02.06.02 Diltiazem Hydrochloride Zemtard®
02.06.02 Diltiazem Hydrochloride Tildiem®
02.06.02 Diltiazem Hydrochloride Adizem-XL®
02.06.02 Diltiazem Hydrochloride Dilcardia® SR
02.06.02 Diltiazem Hydrochloride Dilzem® XL
02.06.02 Diltiazem Hydrochloride Tildem® LA
02.06.02 Diltiazem Hydrochloride Viazem® XL
13.05.02 Dimethyl Fumarate  
13.10.04 Dimeticone Hedrin®
07.01.01 Dinoprostone Propess®
07.01.01 Dinoprostone Prostin E2®
02.09 Dipyridamole 
02.09 Dipyridamole Persantin®
02.09 Dipyridamole Persantin® Retard
06.06.02 Disodium Pamidronate 
02.03.02 Disopyramide 
13.05.02 Dithranol Dithrocream®
13.05.02 Dithranol Ointment BP 
13.05.02 Dithranol Paste BP 
02.07.01 Dobutamine 
08.01.05 Docetaxel Taxotere®
01.06.02 Docusate 
01.06.02 Docusate Sodium 
05.03.01 Dolutegravir 
05.03.01 Dolutegravir, abacavir & lamivudine Triumeq®
04.06 Domperidone 
04.11 Donepezil Aricept®
02.07.01 Dopamine 
02.07.01 Dopexamine 
03.07 Dornase Alfa Pulmozyme®
11.06 Dorzolomide Trusopt®
11.06 Dorzolomide 2% with Timolol 0.5% Cosopt®
04.03.01 Dosulepin 
13.02.01 DoubleBase ® 
03.05.01 Doxapram Dopram®
02.05.04 Doxazosin 
07.04.01 Doxazosin 
13.03 Doxepin Xepin®
08.01.02 Doxorubicin 
08.01.02 Doxorubicin Caelyx®
05.01.03 Doxycycline 
05.04.01 Doxycycline 
02.03.02 Dronedarone Multaq®
04.06 Droperidol Xomolix®
06.01.02.03 Dulaglutide 

note  Second line WEEKLY preparation

04.03.04 Duloxetine 

See SPC for licenced use

For CHFT neuropathic pain guidance see link below

07.04.02 Duloxetine Yentreve®
08.01.05 Durvalumab Imfinzi ®
06.04.02 Dutasteride Avodart®
06.04.01.02 Dydrogesterone Duphaston® HRT
02.08.02 Edoxaban Lixiana®
05.03.01 Efavirenz Sustiva®
05.03.03.02 Elbasvir/Grazoprevir Zepatier®

Restricted to use as per NICE TA 413

09.01.04 Eltrombopag Revolade®

Chronic immune (idiopathis) thrombocytopenic purpura in patients refractory to other treatments e.g. corticosteroids or immunoglobulins

01.04.02 Eluxadoline Truberzi®

To ensure review is undertaken and stop eluxadoline at 4 weeks if there is inadequate relief of the symptoms of irritable bowel syndrome with diarrhoea.

11.04.02 Emedastine Emadine®
13.02.01.01 Emollient Bath Additive Zerolatum®
13.02.01.01 Emollient Bath Additive with Anitmicrobials Emulsiderm®
13.02.01 Emollient preparation Drapolene®
13.02.01 Emollient preparation Epaderm®
13.02.01 Emollient preparation containing Urea Balneum®
06.01.02.03 Empagliflozin Jardiance▼®

Updated 25th October 2019 

Revised SPCs: Empagliflozin products (Jardiance, Synjardy, Glyxambi)

SPCs updated to state treatment should be interrupted in patients hospitalised for major surgical procedures/acute serious medical illnesses and monitoring of ketones recommended (blood preferred to urine levels), and treatment restarted when ketones normal and patient.

05.03.01 Emtricitabine Emtriva®
05.03.01 Emtricitabine + rilpivirine + tenofovir alafenamide Odefsey®
05.03.01 Emtricitabine + tenofovir alafenamide Descovy®
05.03.01 Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera®
13.02.01 Emulsifying Ointment BP 
02.05.05.01 Enalapril  
05.03.01 Enfuvirtide Fuzeon®
04.09.01 Entacapone Comtess®
05.03.03.01 Entecavir Baraclude®
08.03.04.02 Enzalutamide Xtandi®
02.07.02 Ephedrine 
12.02.02 Ephedrine 
08.01.02 Epirubicin 
02.02.03 Eplerenone 
09.01.03 Epoetin alfa Eprex®
09.01.03 Epoetin beta NeoRecormon®
02.08.01 Epoprostenol Flolan®
02.09 Eptifibatide Integrilin®
09.06.04 Ergocalciferol 
07.01.01 Ergometrine Maleate 
07.01.01 Ergometrine Maleate and Oxytocin Syntometrine®
08.01.05 Eribulin Halaven®
08.01.05 Erlotinib Tarceva®
05.01.02.02 Ertapenem Invanz®
06.01.02.03 Ertugliflozin Steglatro▼®
05.01.05 Erythromycin 
02.04 Esmolol 
01.03.05 Esomeprazole 
10.01.03 Etanercept Erelzi®
13.05.03 Etanercept Enbrel®
05.01.09 Ethambutol  

Restricted Item Information on restriction :

Restricted to specialist respiratory / microbiology use only

Only tablets are available however these may be crushed and mixed with water for administration. This should only be done under the advice of the prescriber and/or pharmacist.  

06.04.01.01 Ethinylestradiol 
07.03.01 Ethinylestradiol / levonorgestrel phased pill TriRegol®, Logynon®
07.03.01 Ethinylestradiol 20 mcg / norethisterone 1mg Loestrin 20®
07.03.01 Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel®, Mercilon®
07.03.01 Ethinylestradiol 20mcg / gestodene 75 mcg Millinette®, Femodette®, Juliperla®
07.03.01 Ethinylestradiol 30 mcg / drospirenone 3 mg Yasmin®
07.03.01 Ethinylestradiol 30mcg / gestodene 75 mcg Millinette®, Femodene®,Sofiperla®
04.08.01 Ethosuximide 
15.02 Ethyl Chloride Cryogesic® Spray
15.01.01 Etomidate Hypnomidate®
08.01.04 Etoposide 
10.01.01 Etoricoxib Arcoxia®
05.03.01 Etravirine Intelence®
08.01.05 Everolimus Afinitor®
08.03.04.01 Exemestane 
02.12 Ezetimibe Ezetrol®
05.03.02.01 Famciclovir Famvir®
10.01.04 Febuxostat Adenuric®
02.12 Fenofibrate 
02.12 Fenofibrate Lipantil®
04.07.02 Fentanyl 
04.07.02 Fentanyl 
15.01.04.03 Fentanyl 
09.01.01.02 Ferric Carboxymaltose Ferinject®
09.01.01.01 Ferrous Fumarate 

note Note that Ferrous sulfate is the preferred formulary choice. 

Please discuss with pharmacy before prescribing ferrous fumarate. 

This should only occur as an exception when ferrous sulfate or sodium feredetate has not been tolerated. 

 

Dosage: Once daily is the first choice . This is usually provides appropriate absoprtion of iron, taking more frequently may increase side effects with little or no added benefit. 

09.01.01.01 Ferrous Sulphate 

Dosage: Once daily is the first choice . This is usually provides appropriate absoprtion of iron, taking more frequently may increase side effects with little or no added benefit. 

03.04.01 Fexofenadine 
05.01.07 Fidaxomicin Dificlir®
09.01.06 Filgrastim Zarzio®, Accofil®
06.04.02 Finasteride 
02.03.02 Flecainide 
01.06.05 Fleet Phospho-soda ® 
05.01.01.02 Flucloxacillin 
05.02 Fluconazole 
05.02 Flucytosine Ancotil®
08.01.03 Fludarabine Phosphate Fludara®
06.03.01 Fludrocortisone 
13.04 Fludroxycortide  Haelan®
15.01.07 Flumazenil 
12.01.01 Flumetasone 0.02% with Clioquinol 1% Locorten-Vioform®
11.04.01 Fluocinolone intravitreal implant Iluvien®
11.08.02 Fluorescein Sodium 
11.04.01 Fluorometholone FML®
08.01.03 Fluorouracil 
13.08.01 Fluorouracil Efudix®
13.08.01 Fluorouracil Actikerall®
04.03.03 Fluoxetine 
04.02.02 Fluphenazine Decanoate Modecate®
03.02 Fluticasone furoate & vilanterol Relvar Ellipta®
03.01.04 fluticasone furoate/vilanterol trifenatate/umeclidinium bromide Trelegy Ellipta ®
12.02.01 Fluticasone Propionate 
13.04 Fluticasone Propionate Cutivate®
03.02 Fluticasone propionate and formoterol Flutiform®
03.02 Fluticasone propionate and salmeterol Sirdupla®, Seretide®, Airflusal®
09.01.02 Folic Acid 
06.05.01 Follitropin Alfa  Gonal-F®
02.08.01 Fondaparinux Arixtra®
13.07 Formaldehyde Veracur®
03.01.01.01 Formoterol  
05.03.01 Fosamprenavir Telzir®
04.06 Fosaprepitant Ivemend®
05.03.02.02 Foscarnet Sodium Foscavir®
04.07.04.02 Fremanezumab Ajovy ®

For use in line with NICE guidance

NICE TA631:Fremanezumab for preventing migraine

 

08.03.04.01 Fulvestrant Faslodex®

formulary- restricted use

02.02.02 Furosemide 
11.03.01 Fusidic Acid 
04.08.01 Gabapentin 
04.11 Galantamine Reminyl®
04.11 Galantamine Reminyl® XL
05.03.02.02 Ganciclovir Cymevene®
11.03.03 Ganciclovir 0.15% ophthalmic gel Virgan®
01.01.02 Gaviscon Advance® 

Chewable tablets only 

08.01.05 Gefitinib Iressa ®
09.02.02.02 Gelatin Geloplasma®
08.01.03 Gemcitabine Gemzar®
07.01.01 Gemeprost 
05.01.04 Gentamicin 
11.03.01 Gentamicin Genticin®
06.01.02.01 Gliclazide 
06.01.02.01 Glimepiride 
06.01.04 Glucagon GlucaGen® HypoKit
09.02.02.01 Glucose Intravenous 
06.01.06 Glucose test strips 
01.06.02 Glycerol 
02.06.01 Glyceryl Trinitrate 
02.06.01 Glyceryl Trinitrate Nitromin®
01.07.04 Glyceryl Trinitrate 0.4% 
07.04.04 Glycine 
03.01.04 Glycopyrrolate/ indacaterol inhaler Ultibro Breezhaler®
03.01.02 Glycopyrronium Seebri breezhaler®
13.12 Glycopyrronium 
15.01.03 Glycopyrronium 
15.01.03 Glycopyrronium Bromide 1 mg/5 ml Oral Solution 

For control of upper airways secretions and hypersalivation in adults (off-label use).

01.05.03 Golimumab 
10.01.03 Golimumab Simponi®
06.05.01 Gonadorelin HRF®
06.07.02 Goserelin 
08.03.04.01 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex® LA
05.02 Griseofulvin 
13.05 Guselkumab Tremfya ®

Restricted to use as per Biologic treatment pathways

04.02.01 Haloperidol 
04.02.02 Haloperidol Haldol Decanoate®
02.08.01 Heparin 
02.08.01 Heparin 
13.13 Heparinoid 0.3% Hirudoid®
13.10.05 Histoacryl ® 
06.05.01 Human Menopausal Gonadotrophins Menopur®
10.03.01 Hyaluronidase Hyalase®
02.05.01 Hydralazine 
02.05.01 Hydralazine Hydrochloride Apresoline®
01.05.02 Hydrocortisone 
06.03.02 Hydrocortisone 
12.03.01 Hydrocortisone Corlan®
13.04 Hydrocortisone 
13.04 Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort®
12.01.01 Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC
13.04 Hydrocortisone Butyrate Locoid®
13.11.06 Hydrogen Peroxide Crystacide®
09.01.02 Hydroxocobalamin 

See cyanocobalamin for guidance during the COVID-19 pandemic 

08.01.05 Hydroxycarbamide 
09.01.03 Hydroxycarbamide Siklos®
10.01.03 Hydroxychloroquine 
11.08.01 Hydroxypropyl Guar Systane®
03.04.01 Hydroxyzine Ucerax®
01.02 Hyoscine Butylbromide 
04.06 Hyoscine Hydrobromide 
15.01.03 Hyoscine Hydrobromide 
11.08.01 Hypromellose 
06.06.02 Ibandronic Acid 
08.01.05 Ibrutinib Imbruvica®
10.01.01 Ibuprofen 
08.01.02 Idarubicin Zavedos®
08.01.05 Idelalisib Zydelig®
08.01.01 Ifosfamide Mitoxana®
08.01.05 Imatinib Gilvec®
05.01.02.02 Imipenem with Cilastatin 
04.03.01 Imipramine 
13.07 Imiquimod Aldara®
03.01.01.01 Indacaterol Onbrez
02.02.01 Indapamide Natrilix®
10.01.01 Indometacin 
01.01.02 Infant Gaviscon ® 
01.05.03 Infliximab 
10.01.03 Infliximab Remicade®
13.05.03 Infliximab Remicade®
13.08.01 Ingenol mebutate Picato®
06.01.01.01 Insulin Humulin® S
06.01.01.01 Insulin Actrapid®
06.01.01.01 Insulin Insuman® Rapid
06.01.01.01 Insulin Aspart  NovoRapid®
06.01.01.01 Insulin aspart Fiasp®
06.01.01.01 Insulin bovine Hypurin® Bovine Neutral
06.01.01.02 Insulin degludec Tresiba®
06.01.01.02 Insulin Detemir Levemir®
06.01.01.02 Insulin Glargine Toujeo®

Restricted to specialist use 

SoloStar pen

Each pen contains 1.5 ml of solution for injection, equivalent to 450 units.

DoubleStar pen

Each pen contains 3 ml of solution for injection, equivalent to 900 units.

06.01.01.02 Insulin Glargine Lantus®

Lantus available for patients already using. Semglee is the trust first line choice for patients starting insulin glargine.

06.01.01.02 Insulin Glargine Semglee® First choice for Insulin Glargine
06.01.01.01 Insulin Lispro 100 units/ml Humalog®
06.01.01.01 Insulin Lispro 200 units/ml Humalog®
06.01.01.01 Insulin porcine  Hypurin® Porcine Neutral
06.01.01.02 Insulin Zinc suspension Hypurin®Bovine Lente
08.02.04 Interferon Alfa 
07.03.04 Intra-uterine Contraceptive Devices Load® 375
07.03.04 Intra-uterine Contraceptive Devices T-Safe® CU 380 A
07.03.02.03 Intra-uterine Progestogen Only System Mirena®
06.02.02 Iodine and Iodide 
03.01.02 Ipratropium Bromide Atrovent®
03.01.02 Ipratropium Bromide Ipratropium Steri-Neb®
12.02.02 Ipratropium Bromide Rinatec®
02.05.05.02 Irbesartan 
08.01.05 Irinotecan Hydrochloride 
09.01.01.02 Iron Dextran CosmoFer®

If Ferinject unsuitable 

15.01.02 Isoflurane 
05.01.09 Isoniazid 

Restricted Item Information on restriction

Restricted to specialist respiratory / microbiology use only

06.01.01.02 Isophane Insulin Hypurin® Bovine Isophane
06.01.01.02 Isophane Insulin Hypurin® Porcine Isophane
06.01.01.02 Isophane Insulin Insulatard®
06.01.01.02 Isophane Insulin Humulin® I
06.01.01.02 Isophane Insulin Insuman® Basal
02.06.01 Isosorbide Mononitrate 
02.06.01 Isosorbide Mononitrate MR 
13.06.01 Isotretinoin Isotrex® gel
13.06.02 Isotretinoin Roaccutane®
01.06.01 Ispaghula Husk 
05.02 Itraconazole 
02.06.03 Ivabradine 
13.06 Ivermectin cream Soolantra®
08.01.05 Ixazomib Ninlaro®
13.05.02 Ixekizumab Taltz®
04.07.03 Ketamine (oral) 

Restricted Item Information on restriction : restricted to specialist pain team use

15.01.01 Ketamine injection 
13.09 Ketoconazole 
06.01.06 Ketones test strips 
11.08.02 Ketorolac Acular®

Due to supply issues Bromfenac is being used instead of Ketorolac (Last update April 2019)

15.01.04.02 Ketorolac Toradol®
02.04 Labetalol 
04.08.01 Lacosamide  Vimpat ®
07.02.02 Lactic acid Balance Activ Rx®
01.06.04 Lactulose 
05.03.01 Lamivudine Zeffix®
04.08.01 Lamotrigine 
08.02.04 Lanadelumab Takhzyro®

As per the NICE TA606 - for preventing recurrent attacks of hereditary angioedema

08.03.04.03 Lanreotide Somatuline®
01.03.05 Lansoprazole 
09.05.02.02 Lanthanum Fosrenol ®

Restricted specifically to control of hyperphosphataemia in patients with chronic renal failure. Only to be initiated by the renal team.

https://www.swyapc.org/shared-care-guidelines/

08.01.05 Lapatinib Tyverb®
08.01.05 Larotrectinib Vitrakvi®
11.06 Latanoprost Xalatan®
11.06 Latanoprost 0.005% with Timolol 0.5% Xalacom®
10.01.03 Leflunomide 
08.02.04 Lenalidomide 
02.06.02 Lercanidipine 
08.03.04.01 Letrozole 
06.07.02 Leuprorelin 
08.03.04.02 Leuprorelin Acetate Prostap® SR
08.03.04.02 Leuprorelin Acetate Prostap® 3
04.08.01 Levetiracetam 
11.06 Levobunolol Betagan®
15.02 Levobupivacaine Chirocaine®
09.08.01 Levocarnitine Carnitor®
04.09.01 Levodopa 
05.01.12 Levofloxacin 
11.03.01 Levofloxacin 
04.06 Levomepromazine 
07.03.05 Levonorgestrel 
06.02.01 Levothyroxine 
02.03.02 Lidocaine 
15.02 Lidocaine  Versatis®

Red - Secondary care use only

15.02 Lidocaine 
15.02 Lidocaine 4% cream LMX4®
01.06.07 Linaclotide Constella®
06.01.02.03 Linagliptin Trajenta▼®
05.01.07 Linezolid 
06.02.01 Liothyronine 

To be used in line with the commissioning statement available at

https://www.swyapc.org/search-individual-drug/ 

13.02.01 Liquid and White Soft Paraffin Ointment (50:50) 
11.08.01 Liquid Paraffin eye ointment 

Products available include Hydramed Night, Xailin Night, Hylo-Night (previously called VitA-Pos).

06.01.02.03 Liraglutide Victoza®

note  First line DAILY preparation

02.05.05.01 Lisinopril 
04.02.03 Lithium Carbonate Camcolit ® 400mg/ Essential Pharma 250mg
04.02.03 Lithium Carbonate Liskonum®
04.02.03 Lithium Carbonate Priadel®
04.02.03 Lithium Citrate Li-Liquid®
04.02.03 Lithium Citrate Priadel®
06.01.02.03 Lixisenatide Lyxumia▼®

note  Second line DAILY preparation

11.04.02 Lodoxamide Alomide®
04.03.01 Lofepramine 
08.01.01 Lomustine 
01.04.02 Loperamide 
05.03.01 Lopinavir and Ritonavir Kaletra®
03.04.01 Loratadine 
04.01.02 Lorazepam 
04.08.02 Lorazepam 
15.01.04.01 Lorazepam 
08.01.05 Lorlatinib Lorviqua®
02.05.05.02 Losartan 
11.04.01 Loteprednol Lotemax®
05.01.03 Lymecycline Tetralysal® 300
01.06.04 Macrogol oral powder 

Laxido is the macrogol currently used by CHFT 

01.06.05 Macrogols Moviprep®
09.05.01.03 Magnesium Aspartate Magnaspartate®
09.05.01.03 Magnesium Glycerophosphate 
09.05.01.03 Magnesium Sulphate 
13.10.05 Magnesium Sulphate Paste BP 
01.01.01 Magnesium Trisilicate 
13.10.04 Malathion 0.5% Derbac-M®
02.02.05 Mannitol 
05.03.01 Maraviroc Celsentri®
05.05.01 Mebendazole 
01.02 Mebeverine 
01.02 Mebeverine Colofac® MR
01.02 Mebeverine Hydrochloride Colofac®
06.04.01.02 Medroxyprogesterone Acetate Provera®
06.04.01.02 Medroxyprogesterone Acetate Climanor®
07.03.02.02 Medroxyprogesterone acetate Sayana Press®
07.03.02.02 Medroxyprogesterone Acetate Depo-Provera®
08.03.02 Medroxyprogesterone Acetate Provera®
05.04.01 Mefloquine Lariam®
08.03.02 Megestrol Acetate Megace®
04.01.01 Melatonin 

Specialist use only for :

  • Treatment of sleep disorders in children and young people under 18 years
  • Cerebral palsy
08.01.01 Melphalan 
04.11 Memantine Ebixa®
09.06.06 Menadiol Sodium Phosphate 
15.02 Mepivacaine Scandonest Plain®
04.07.02 Meptazinol Meptid®
01.05.03 Mercaptopurine 
08.01.03 Mercaptopurine 
05.01.02.02 Meropenem Meronem®
01.05.01 Mesalazine 

First line oral - Octasa

First line rectal - Salofalk

 

01.05.01 Mesalazine  Octasa®

Mesalazine  (Octasa) 1600mg- restricted

08.01 Mesna 
02.07.02 Metaraminol 
06.01.02.02 Metformin 
06.01.02.02 Metformin Hydrochloride Glucophage® SR
04.07.02 Methadone 

To be used by pain team / specialist in pain managment only if being used as an analgesic 

 

04.10.03 Methadone 
05.01.13 Methenamine Hippurate Hiprex®
10.02.02 Methocarbamol Robaxin®
01.05.03 Methotrexate 
08.01.03 Methotrexate 
10.01.03 Methotrexate 
13.05.03 Methotrexate 
13.08.01 Methyl-5-Aminolevulinate Metvix®

Restricted Item Information on restriction

 

Restricted to dermatology use only

02.05.02 Methyldopa 
02.05.02 Methyldopa Aldomet®
01.06.06 Methylnaltrexone Relistor®
06.03.02 Methylprednisolone 
10.01.02.02 Methylprednisolone Acetate Depo-Medrone®
04.06 Metoclopramide 
02.02.01 Metolazone 
02.04 Metoprolol 
05.01.11 Metronidazole 
05.04.02 Metronidazole 
07.02.02 Metronidazole Zidoval®
13.10.01.02 Metronidazole topical 0.75% 
06.07.03 Metyrapone Metopirone®
07.02.02 Miconazole Gyno-Daktarin®
12.03.02 Miconazole Daktarin®
13.10.02 Miconazole Daktarin®
04.08.02 Midazolam 
15.01.04.01 Midazolam Hypnovel®
07.01.02 Mifepristone Mifegyne®
02.01.02 Milrinone Primacor®
05.01.03 Minocycline 
07.04.02 Mirabegron Betmiga®
04.03.04 Mirtazapine 
01.03.04 Misoprostol 
08.01.02 Mitomycin 
08.01.02 Mitoxantrone (Mitozantrone) 
15.01.05 Mivacurium Mivacron®
04.04 Modafinil Provigil®

restricted to specialist / consultant initiation

12.02 Moffetts Solution  

Topical vasoconstriction for sinus surgery

12.02.01 Mometasone Furoate Nasonex®
13.04 Mometasone Furoate 0.1% Elocon®
03.03.02 Montelukast Singulair®
04.07.02 Morphine 
04.07.02 Morphine Salts 
05.01.12 Moxifloxacin 
02.05.02 Moxonidine Physiotens®
09.06.07 Multivitamin preparations Dalivit®
09.06.07 Multivitamin preparations Abidec®
12.02.03 Mupirocin 2% Bactroban Nasal®
13.10.01.01 Mupirocin 2% Bactroban®

Restricted to MRSA suppression treatment and trust antibacterial guidelines

08.02.01 Mycophenolate Mofetil 
06.07.02 Nafarelin 
02.06.04 Naftidrofuryl Oxalate Praxilene®
01.06.06 Naloxegol 
15.01.07 Naloxone 
20 Naltrexone 

unlicensed unlicensed

 

Restricted Item Information on restriction

Restricted to specialist use - to treat fibromyalgia in patients unresponsive to other treatments.

 

 

10.01.01 Naproxen 
04.07.04.01 Naratriptan Naramig®
02.04 Nebivolol Nebilet®
11.04.02 Neodocromil Rapitil®
05.01.04 Neomycin Sulphate 
10.02.01 Neostigmine 
15.01.06 Neostigmine 
15.01.06 Neostigmine with Glycopyrronium 
08.03.04.01 Neratinib 

Restricted to the use as per NICE TA612

05.03.01 Nevirapine Viramune®
02.06.03 Nicorandil 
04.10.02 Nicotine 
02.06.02 Nifedipine 
02.06.02 Nifedipine Adalat® LA
08.01.05 Nilotinib Tasigna®
02.06.02 Nimodipine Nimotop®
08.02.04 Niraparib Zejula®
04.01.01 Nitrazepam 
05.01.13 Nitrofurantoin 
08.02.04 Nivolumab Opdivo®
02.07.02 Noradrenaline / Norepinephrine 
06.04.01.02 Norethisterone 
06.04.01.02 Norethisterone Primolut N®
06.04.01.02 Norethisterone Utovlan®
04.03.01 Nortriptyline 
13.04 Nystaform-HC ® 
12.03.02 Nystatin Nystan®
08.02.03 Obinutuzumab Gazyvaro ®

NHSE routine comissioned. CDF then NHSE- from 90 days following publication of the final treatment guideline. 

11.08.02 Ocriplasmin Jetrea®
08.03.04.03 Octreotide Sandostatin®
06.04.01.01 Oestrogen only HRT gel Oestrogel

Estradiol pump pack 0.06% available at chft.

06.04.01.01 Oestrogen only HRT patch Estradot, Evorel
06.04.01.01 Oestrogen only HRT tablet Elleste-Solo, Premarin
06.04.01.01 Oestrogens for HRT FemSeven® Conti
06.04.01.01 Oestrogens for HRT Angeliq®
06.04.01.01 Oestrogens for HRT FemSeven® Sequi
07.02.01 Oestrogens, Topical Estring®
07.02.01 Oestrogens, Topical Ovestin®
07.02.01 Oestrogens, Topical Vagifem®
08.02.03 Ofatumumab Arzerra®
05.01.12 Ofloxacin 
13.02.01.01 Oilatum® Plus 
04.02.01 Olanzapine 
04.02.02 Olanzapine Embonate ZypAdhera®
12.01.03 Olive Oil Ear Drops 
03.01.01.01 Olodaterol Striverdi Respimat®
03.04.02 Omalizumab Xolair®
02.12 Omega-3-Acid Ethyl Esters Omacor®
01.03.05 Omeprazole 
01.03.05 Omeprazole IV 
04.06 Ondansetron 
04.09.01 Opicapone 

Restricted Item Information on restriction

Specialist initiation only for advanced disease with motor fluctuations

07.03.02 Oral Progestogen-Only Contraceptives Norgeston®
07.03.02 Oral Progestogen-Only Contraceptives Micronor®
07.03.02 Oral Progestogen-Only Contraceptives Noriday®
07.03.02 Oral Progestogen-Only Contraceptives Cerazette®
09.02.01.02 Oral Rehydration Salts 
04.05.01 Orlistat 
04.09.02 Orphenadrine 
05.03.04 Oseltamivir Tamiflu®
08.02.04 Osimertinib Tagrisso

AS PER MMC MEETING 12.03.20

 

As per Andrew email from mmc may 2020: Not recommended for treatment of untreated EGFR mutation - posotive NSCS

Not recommended for use

08.01.05 Oxaliplatin 
04.08.01 Oxcarbazepine Trileptal®
11.07 Oxybuprocaine Minims®
07.04.02 Oxybutynin Hydrochloride Kentera®
04.07.02 Oxycodone 
05.01.03 Oxytetracycline 
07.01.01 Oxytocin Syntocinon®
08.01.05 Pablociclib Ibrance®
08.01.05 Paclitaxel Abraxane®
08.01.05 Paclitaxel 
08.03.04.01 Palbociclib Ibrance®

AS per mmc meeting 12.03.2020

05.03.05 Palivizumab Synagis®
01.09.04 Pancreatin Pancrex® V

Manufacturer states 2.5mL spoon = 2g of powder

01.09.04 Pancreatin Creon® 40000
01.09.04 Pancreatin Creon® Micro
01.09.04 Pancreatin Creon® 25000
01.09.04 Pancreatin 
15.01.05 Pancuronium 
08.01.05 Panitumumab Vectibix®
08.01.05 Panobinostat Farydak®
04.07.01 Paracetamol 
04.08.03 Paracetamol 
15.01.04.02 Parecoxib Dynastat®
04.03.03 Paroxetine 
09.01.06 Pegfilgrastim Neulasta®
08.02.04 Peginterferon Alfa Pegasys®
08.01.03 Pemetrexed Alimta®
08.02.04 Pemrolizumab Keytruda®
10.01.03 Penicillamine 
20 PENTOSAN POLYSULPHATE Capsules 50 mg Elmiron®
01.02 Peppermint Oil Colpermin®
01.02 Peppermint Oil 
01.02 Peppermint Oil Mintec®
01.01.02 Peptac ® 
04.08.01 Perampanel Fycompa®

Restricted to specialist use only - Neurology 

Green Green Specialist initiation

Notes: Third line -  in cases where more than two monotherapies have failed as well as combination medications have failed we would consider it at this point.

04.09.01 Pergolide 
13.10.04 Permethrin 1% Lyclear® Creme Rinse
13.10.04 Permethrin 5% Lyclear® Dermal Cream
08.01.05 Pertuzumab Perjeta®
04.07.02 Pethidine 
04.03.02 Phenelzine Nardil®
02.08.02 Phenindione 
04.08.01 Phenobarbital 
04.08.02 Phenobarbital injection 
01.07.03 Phenol, Oily 
02.05.04 Phenoxybenzamine Hydrochloride 
05.01.01.01 Phenoxymethylpenicillin 
02.07.02 Phenylephrine 
11.05 Phenylephrine Hydrochloride Minims® Phenylephrine Hydrochloride
11.05 Phenylephrine Hydrochloride  Mydriasert®
04.08.01 Phenytoin 
04.08.02 Phenytoin 
03.09.01 Pholcodine Linctus, BP 
09.05.02.01 Phosphate Polyfusor ® 
09.05.02.01 Phosphate supplements Phosphate-Sandoz®
01.06.05 Phosphates (Oral) OsmoPrep®
01.06.04 Phosphates (Rectal) Fleet® Ready to use Enema
01.06.04 Phosphates (Rectal) 
09.06.06 Phytomenadione 
11.06 Pilocarpine 
12.03.05 pilocarpine Hydrochloride Salagen®
11.06 Pilocarpine preservative free 
13.05.03 Pimecrolimus Elidel®
06.01.02.03 Pioglitazone Actos®
05.01.01.04 Piperacillin and Tazobactam 
10.01.01 Piroxicam 
05.01.01.05 Pivmecillinam Selexid®
08.01.02 Pixantrone 
04.07.04.02 Pizotifen 
13.07 Podophyllotoxin Condyline®
08.01.05 Polatuzumab Vedotin Polivy®

As per MMC September 2020

11.03.01 Polihexanide 

Restricted to use by ophthalmology or as recommended by microbiology 

The trust stocks 0.02% 

13.10.01.01 Polyfax ® 
09.02.01.01 Polystyrene Sulphonate Resins Calcium Resonium®
13.09 Polytar ® 
11.08.01 Polyvinyl Alchohol SnoTears®
08.02.04 Pomalidomide Imnovid®
08.01.05 Ponatinib Iclusig®
03.05.02 Poractant Alfa Curosurf®
05.02 Posaconazole (IV) Noxafil®
05.02 Posaconazole (oral) Noxafil®
09.02.01.01 Potassium Chloride Sando-K®
09.02.01.01 Potassium Chloride Kay-Cee-L®
07.04.03 Potassium Citrate 
13.11.06 Potassium Permanganate Permitabs®
13.11.04 Povidone-Iodine Betadine® or Videne®
04.09.01 Pramipexole 
02.09 Prasugrel Efient®
02.05.04 Prazosin 
07.04.01 Prazosin 
01.05.02 Prednisolone 

 

Adult use - See BNF

Use in children - See BNFC

 

Restricted Item Plain prednisolone tablets should be used - NOT enteric coated

 

 

Specific information on Infantile spasms

Standard Dose regime:

10mg FOUR times daily for 14 days , then 10mg THREE times daily for 5 days , then 10mg TWICE daily for 5 days , then 10mg ONCE daily for 5 days.

Supply:

prednisolone 10mg/mL  3 x 30mL bottles and 1mL syringe

 

Higher dose regime (60mg daily)

After 1 week the epilepsy specialist nurses will review the patient – if needed they may increase the dose to 20mg THREE times daily then give a reducing regime. Reducing regime is as per BNFC

Supply:

If this occurs a further 30mL will need to be supplied against the original prescription – only on the direction of the epilepsy specialist nurses.

06.03.02 Prednisolone 
11.04.01 Prednisolone Pred Forte®
12.01.01 Prednisolone ear drops Predsol®
11.04.01 Prednisolone eye drops 
11.04.01 Prednisolone preservative free eye drops 
04.08.01 Pregabalin 
15.02 Prilocaine Hydrochloride Citanest®
15.02 Prilocaine Hydrochloride Prilotekal®
05.04.01 Primaquine 
04.08.01 Primidone 
08.01.05 Procarbazine 
04.02.01 Prochlorperazine 
04.06 Prochlorperazine 
01.07.02 Proctosedyl ® 
04.09.02 Procyclidine 
13.10.05 Proflavine Cream, BPC  
06.04.01.02 Progesterone Crinone®
06.04.01.02 Progesterone Cyclogest®
06.04.01.02 Progesterone Gestone®
05.04.01 Proguanil Hydrochloride 
03.04.01 Promethazine Phenergan®
04.06 Promethazine Hydrochloride Phenergan
04.06 Promethazine teoclate Avomine®
04.01.01 Promethazine Hydrochloride 
02.03.02 Propafenone 
11.03.01 Propamidine Isetionate Brolene® eye drops
15.01.01 Propofol 
02.04 Propranolol 
06.02.02 Propylthiouracil 
02.08.03 Protamine Sulphate 
06.01.01.02 Protamine Zinc Insulin Hypurin® Bovine Protamine Zinc
11.07 Proxymetacaine Minims®
01.06.07 Prucalopride Resolor®
10.02.01 Pyridostigmine Bromide Mestinon®
09.06.02 Pyridoxine Hydrochloride 
05.04.01 Pyrimethamine Darprim®
04.02.01 Quetiapine 
06.07.01 Quinagolide Norprolac®
20 Quinidine Sulphate  

unlicensed unlicensed

Treatment of Arrhythmia. Specialist use only. Unlicensed USA import.

05.04.01 Quinine 
10.02.02 Quinine 

The licensed dose for the treatment and prevention of nocturnal leg cramps in adults is 200–300 mg at night for quinine sulphate (recommended starting dose 200 mg), and is 300 mg at night for the bisulphate. The quinine salt should always be stated when prescribing because 200 mg quinine sulphate is equivalent to around 300 mg quinine bisulphate.

05.03.01 Raltegravir Isentress ®
08.01.03 Raltitrexed Tomudex®
02.05.05.01 Ramipril 
08.01.05 Ramucirumab Cyramza®
11.08.02 Ranibizumab Lucentis®
01.03.01 Ranitidine 

Due to ongoing drug recalls (see https://www.gov.uk/drug-device-alerts ) Ranitidine is restricted on the formulary. This means it should not be started in new patients or continued in patients currently taking ranitidine unless they meet the criteria below.

Exceptions where patients may be able to start ranitidine include:

  • Oncology
  • High C. difficile risk
  • Allergic to PPIs
  • Hyponatraemic

Any other clinical reason for starting / continuing treatment please discuss with medicines information at E: medicines.information@cht.nhs.uk or T: 01422 224356

 

Information updated 05/12/2019

02.06.03 Ranolazine Ranexa®
04.09.01 Rasagiline 
10.01.04 Rasburicase Fastertec®
15.01.04.03 Remifentanil Ultiva®
06.01.02.03 Repaglinide Prandin®
04.08.01 Retigabine 
05.03.05 Ribavirin Virazole®
08.03.04.01 Ribociclib Kisqali®
05.01.07 Rifaximin Targaxan®

Green SI Green Specialist initiation - Prevention of hepatic encephalopathy in adult patients

Trust to supply initially then GP to continue.

 

Red Unlicensed indication - small intestine bacterial overgrowth (SIBO) and for the treatment of chronic refractory pouchitis .

Only use by gastroenterologist  specifically in patients where IBS symptoms are due to SIBO.

 

See the area prescribing details - click here

 

 

05.03.01 Rilpivirine hydrochloride Edurant®
04.09.03 Riluzole Rilutek®
06.06.02 Risedronate 
04.02.01 Risperidone 
04.02.02 Risperidone Risperdal Consta®
05.03.01 Ritonavir Norvir®
08.02.03 Rituximab Truxima®
02.08.02 Rivaroxaban Xarelto®
04.11 Rivastigmine 
15.01.05 Rocuronium Esmeron®
03.03.03 Roflumilast Daxas®
09.01.04 Romiplostim Nplate®
04.09.01 Ropinirole 
02.12 Rosuvastatin 

initiation by Consultants for patients with high lipid levels despite high doses of, or intolerance to other statins.

04.09.01 Rotigotine 
08.01.05 Rucaparib Rubraca®
08.01.05 Ruxolitinib Jakavi®
02.05.05.02 Sacubitril valsartan Entresto®

Green Specialist initiation - Cardiology 

04.09.01 Safinamide 

Restricted Item Information on restriction

Specialist initiation only

03.01.01.01 Salbutamol 
07.01.03 Salbutamol 
13.07 Salicylic Acid Occlusal®
13.07 Salicylic Acid 16.7% with Lactic Acid 16.7% Salactol®
12.03.05 Salivix ® 
03.01.01.01 Salmeterol 
09.05.01.01 Sandocal-1000 ® 
05.03.01 Saquinavir Invirase®
10.01.03 Sarilumab Kevzara®
01.07.02 Scheriproct® ointment 
13.05.02 Sebco ® 
04.09.01 Selegiline Hydrochloride 
09.05.05 Selenium Selenase®
13.09 Selenium Sulphide Selsun®
06.01.02.03 Semaglutide Ozempic

note First line WEEKLY preparation

01.06.02 Senna 
04.03.03 Sertraline 
09.05.02.02 Sevelamer Carbonate Renvela®
09.05.02.02 Sevelamer Hydrochloride  Renagel®
15.01.02 Sevoflurane 
13.09 Shampoos Ceanel Concentrate®
07.04.05 Sildenafil 
13.07 Silver Nitrate 40% pencil with potassium nitrate 60% AVOCA®
13.07 Silver Nitrate 95% with Potassium Nitrate 5% AVOCA®
13.10.01.01 Silver Sulfadiazine Flamazine®
01.01.01 Simeticone infacol®
03.09.02 Simple Linctus, BP 
03.09.02 Simple Linctus, Paediatric BP 
02.12 Simvastatin 
08.02.02 Sirolimus Rapamune®
06.01.02.03 Sitagliptin Januvia®
09.02.01.03 Sodium Bicarbonate 
09.02.02.01 Sodium Bicarbonate 

Sodium Bicarbonate polyfusors (1.26%, 1.4%, 2.74% and 8.4%) are out of stock until Autumn 2020, As per andrew email 08.04.2020

12.01.03 Sodium Bicarbonate 
03.01.05 Sodium Chloride 
13.11.01 Sodium Chloride 0.9% 
11.08.01 Sodium Chloride 0.9% Solutions 
11.08.01 Sodium Chloride 5% eye drops 

Restricted Item Information on restriction

Restricted to specialist use by opthalmology for corneal oedema

Not always in stock , may need ordering as a 'Special' by pharmacy. Discuss with pharmacy.

03.07 Sodium chloride 7% (Hypertonic) 
09.02.02.01 Sodium Chloride Intravenous 
01.06.04 Sodium Citrate 
07.04.04 Sodium Citrate 
06.06.02 Sodium Clodronate 
01.05.04 Sodium cromoglicate Nalcrom®
11.04.02 Sodium Cromoglicate 
09.01.01.01 Sodium Feredetate Sytron®

In patients who require a liquid preparation 

05.01.07 Sodium fusidate 
11.08.01 Sodium Hyaluronate Evolve HA

Evolve HA is the preferred 1st line brand at CHFT.

11.08.01 Sodium Hyaluronate Hylo-Tear®
02.05.01 Sodium nitroprusside 
01.06.02 Sodium Picosulfate 
02.13 Sodium Tetradecyl Sulphate Fibro-Vein®
04.02.03 Sodium valproate 

Restricted Item Information on restriction

Specialist use - healthcare professionals must follow the MHRA guidance on the pregnancy prevention programme 

This must be followed for all girls (of any age) and women of childbearing potential (or their parent/caregiver/responsible person) taking any medicine containing valproate.

Guidance - Click here 

04.08.01 Sodium Valproate 

Restricted Item Information on restriction

Specialist use - healthcare professionals must follow the MHRA guidance on the pregnancy prevention programme 

This must be followed for all girls (of any age) and women of childbearing potential (or their parent/caregiver/responsible person) taking any medicine containing valproate.

Guidance - Click here 

05.03.03.02 Sofosbuvir–velpatasvir–voxilaprevir Vosevi ®

Restricted to use in Chronic Hepatitis C  as per NICE TA 507 - Click here

10.01.03 Soldium Aurothomalate Myocrisin®
07.04.02 Solifenacin Vesicare®
06.05.01 Somatropin 

Current Brand used at CHFT is Omnitrope

02.04 Sotalol 
02.04 Sotalol Hydrochloride Beta-Cardone®
02.04 Sotalol Hydrochloride Sotacor®
02.02.03 Spironolactone 
05.03.01 Stavudine Zerit®
13.11.07 Sterile Larvae (Maggots) LarvE®
12.02.01 Stérimar ® - Natural sea water Stérimar ®

Note this is not a licensed medicine it is a medical device 

05.01 Stimulan® 

restricted - requires microbiologist approval

02.10.02 Streptokinase 
02.10.02 Streptokinase Streptase®
06.06.02 Strontium Ranelate Protelos®
01.03.03 Sucralfate 
09.05.02.02 sucroferric oxyhydroxide Velphoro®

Control of serum phosphorus levels in dialysis patients

01.05.01 Sulfasalazine 
01.05.01 Sulfasalazine Salazopyrin ®

Treatment of acute attack of mild to moderate and severe ulcerative colitis, or active Crohn's disease

10.01.03 Sulfasalazine 
10.01.04 Sulfinpyrazone 
04.02.01 Sulpiride 
04.07.04.01 Sumatriptan 
13.08.01 Sunscreen SunSense

This is restricted to dermatology use only for photosensivitive disorders.

Sunsense SPF 50+ is the current product in use (last updated Aug 2019)

09.03 Supplementary Preparations Cernevit®
09.03 Supplementary Preparations Dipeptiven®
09.03 Supplementary Preparations Glycophos® Sterile Concentrate
09.03 Supplementary Preparations Addiphos®
09.03 Supplementary Preparations Additrace®
09.03 Supplementary Preparations Peditrace®
09.03 Supplementary Preparations Solivito N®
09.03 Supplementary Preparations Vitlipid N®
15.01.05 Suxamethonium Chloride 
08.02.02 Tacrolimus 
13.05.03 Tacrolimus Protopic®
Tacrolimus ointment (Protopic): reminder of a possible risk of malignancies including lymphomas and skin cancers - Drug Safety Update - June 2012 Healthcare professionals are reminded that topically applied tacrolimus (Protopic) may be associated with a possible increased risk of malignancy. Protopic must not be used in patients aged younger than 2 years, and only the lower strength 0.03% version may be used in children aged 2 - 16 years. Drug Safety Update - June 2012
07.04.05 Tadalafil Cialis®
08.03.04.01 Tamoxifen 
07.04.01 Tamsulosin 
04.07.02 Tapentadol Palexia®

Restricted to use by pain consultants for

  • management of  moderate to severe chronic pain in adults, which can be adequately managed only with opioid analgesics
  • patients who have exhausted all first and second line treatment in nociceptive and neuropathic pain
  • used in reducing opioid use as a bridge in treatment of pain in patient supported in reducing opioids
  • Not indicated as a first line management in chronic pain of any cause
05.03.03.02 Telaprevir Incivo®
04.01.01 Temazepam 
15.01.04.01 Temazepam 
08.01.05 Temsirolimus Torisel®
02.10.02 Tenecteplase Metalyse®
05.03.01 Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla®
05.03.01 Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya®
05.03.01 Tenofovir and Emtricitabine Truvada®
05.03.01 Tenofovir Disproxil Viread®
05.03.01 Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®
02.05.04 Terazosin Hytin®
02.05.04 Terazosin 
07.04.01 Terazosin Hytrin®
05.02 Terbinafine 
13.10.02 Terbinafine Hydrochloride 1% Lamisil®
03.01.01.01 Terbutaline 
07.01.03 Terbutaline 
06.06.01 Teriparatide Forsteo®
06.05.02 Terlipressin Glypressin®
06.04.02 Testosterone gel  Tostran®
06.04.02 Testosterone injection Sustanon 250®
06.04.02 Testosterone undecanoate Nebido®
04.09.03 Tetrabenazine Xenazine® 25
11.07 Tetracaine Minims® Amethocaine
15.02 Tetracaine (Amethocaine) Ametop®
06.05.01 Tetracosactide Synacthen®
05.01.03 Tetracycline 
08.02.04 Thalidomide Celgene®
03.01.03 Theophylline 
03.01.03 Theophylline Nuelin® SA
03.01.03 Theophylline Slo-Phyllin®
03.01.03 Theophylline Uniphyllin® Continus
09.06.02 Thiamine 
15.01.01 Thiopental 
02.09 Ticagrelor Brilique®
11.06 Timolol 
03.01.02 Tiotropium Spiriva® or Braltus®
03.01.04 Tiotropium & olodaterol ® Spiolto Respimat
02.09 Tirofiban Aggrastat®
10.02.02 Tizanidine 
05.01.04 Tobramycin 
10.01.03 Tocilizumab RoActemra®
10.01.03 Tofacitinib citrate 
07.04.02 Tolterodine 
06.05.02 Tolvaptan Samsca®

Red Hospital only  

Restrictions in Prescribing Restricted to prescribing by Consultants In Renal Disease in line with NICE TA

Use in the management of hyponatraemia is limited by NHSE - contact Pharmacy before prescribing

 

Licensed indication treatment of adult patients with Hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH).

04.08.01 Topiramate 
08.01.05 Topotecan Hycamtin®
04.07.02 Tramadol 
02.11 Tranexamic Acid 
02.11 Tranexamic Acid Cyklokapron®
08.01.05 Trastuzumab Herceptin®
08.01.05 Trastuzumab emtansine Kadcyla®
11.06 Travoprost Travatan®
11.06 Travoprost with Timolol DuoTrav®
04.03.01 Trazodone 
08.01.05 Tretinoin Vesanoid®
06.03.02 Triamcinolone Kenalog®
10.01.02.02 Triamcinolone Acetonide Kenalog®
10.01.02.02 Triamcinolone Acetonide Adcortyl®
11.04 Triamcinolone Acetonide Triesence ®
  • Diabetic macular oedema in patients where Lucentis and Eylea failed to control the oedema and Ozurdex is not allowed as per NICE as phakic.
  • Post op Cystoid macular oedema non responding to topical treatment or sub-tenon Kenalog
  • Macular telangiectasia type 1 or leaking microaneurisms amenable for laser treatment
12.02.01 Triamcinolone Acetonide Nasacort®
04.02.01 Trifluoperazine 
08.01.05 Trifluridine-tipiracil Lonsurf®
04.09.02 Trihexyphenidyl 
05.01.08 Trimethoprim 
13.04 Trimovate ® 
06.07.02 Triptorelin 
08.03.04.02 Triptorelin Decapeptyl®
11.05 Tropicamide Mydriacyl®
11.05 Tropicamide single use Minims® Tropicamide
07.04.02 Trospium 
20 UBIQUENONE  Co-enzyme Q10

Requires an MMC individual patient funding request. CHFT staff - please complete the application https://intranet.cht.nhs.uk/clinical-information/pharmacy-and-medicines-management/medicines-management-committee/ 

06.07.02 Ulipristal Esmya®

Ulipristal- suspended as per MHRA

Product not available- discuss with pharmacy

07.03.05 Ulipristal EllaOne®
03.01.02 Umeclidinium Incruse Ellipta®
03.01.04 Umeclidinium & vilanterol Anoro Ellipta®
06.05.01 Urofollitropin 
02.10.02 Urokinase 
01.09.01 Ursodeoxycholic acid 
13.05.03 Ustekinumab 

For treatments meeting NICE TA's only (see below) 

05.03.02.01 Valaciclovir Valtrex®
05.03.02.02 Valganciclovir Valcyte®
04.02.03 Valproic Acid Depakote®

Restricted Item Information on restriction

Specialist use - healthcare professionals must follow the MHRA guidance on the pregnancy prevention programme 

This must be followed for all girls (of any age) and women of childbearing potential (or their parent/caregiver/responsible person) taking any medicine containing valproate.

Guidance - Click here 

02.05.05.02 Valsartan 
05.01.07 Vancomycin 
04.10.02 Varenicline Champix®
15.01.05 Vecuronium Norcuron®
13.08.02 Veil ® 
08.01.05 Venetoclax Venclyxto®
04.03.04 Venlafaxine 
02.06.02 Verapamil 
02.06.02 Verapamil Hydrochloride Securon®
02.06.02 Verapamil Hydrochloride Sucuron® SR
02.06.02 Verapamil Hydrochloride Vertab® SR 240
02.06.02 Verapamil Hydrochloride Cordilox®
02.06.02 Verapamil Hydrochloride Half Sucuron® SR
02.06.02 Verapamil Hydrochloride Univer®
04.08.01 Vigabatrin Sabril®
08.01.04 Vinblastine Sulphate 
08.01.04 Vincristine Sulphate 
08.01.04 Vinorelbine 
09.06.07 Vitamin and mineral supplements Forceval®
09.06.07 Vitamin and mineral supplements Forceval Soluble®
09.06.07 Vitamin and mineral supplements Ketovite®
09.06.02 Vitamin B Tablets, Compound Strong 
09.06.01 Vitamins A and D 
05.02 Voriconazole Vfend®
02.08.02 Warfarin 

For all patients initiated on warfarin please ensure the anticoagulant service is informed.

For advice or referrals please call Telephone number 01484 355014

 

When in hospital INR checks should be done:

  • On admission
  • Prior to discharge
  • Daily during acute illness
  • 3 days after a dose change
  • After other medicines are changed; stopped or started.

 

For Slow Loading

 

If a patient does not require rapid initiation e.g. treatment of atrial fibrillation (AF) 2 to 3 mg daily can be given for 7 days then INR checked. (LMWH injections may not be necessary)

 

For inpatient dose adjustments: Loading doses

Rapid Loading dose: 5mg, 5mg, 5mg → INR on day 4

 

UNLESS: Fit young adults, patients > 100kg or if taking rifampicin, carbamazepine or phenytoin → 8mg, 8mg, 8mg

 

OR: Frail elderly or oncology patients → 3mg, 3mg, 3mg

 

 

For dose adjustments after 3 days loading dose use the below table

Target INR 2.5 (Range 2-3)

(Use table for predicting first dose following rapid loading)

INR

8mg, 8mg, 8mg

5mg, 5mg, 5mg

3mg, 3mg, 3mg

<1.5

7mg

5mg

3mg

1.8

6mg

4mg

2mg

2.0

5mg

3mg

1.5mg

2.2

4.5mg

3mg

1mg

2.5

4mg

3mg

1mg

3.0

3.5mg

2mg

0.5mg

3.5

3mg

-

-

4.0

3mg

-

-

 

 

 

For Dose reduction information

INR

Target INR 2.5

(Range 2.0 -3.0)

Target INR 3.5

(Range 3.0 -4.0)

% dose reduction

No. days dose omitted

% dose reduction

No. days dose omitted

3.0 - 3.5

15

Do not omit

-

-

3.6 - 4.0

20

-

-

4.1 - 5.0

25

15

 -

5.1 - 6.0

25

Omit for 1 day

20

Do not omit

6.1 - 8.0

33

Omit for 2 days

33

Omit for 2 days

>8.0

50

Omit for 3 days (check INR in the interim)

50

Omit for 3 days (check INR in the interim)

 

 

09.02.02.01 Water for Injection 
13.02.01 White Soft Paraffin BP 
12.02.02 Xylometazoline Otrivine®
01.07.02 Xyloproct ® 
13.02.01 Yellow Soft Parrafin BP 
04.01.01 Zaleplon Sonata®
05.03.04 Zanamivir inhalation Relenza®
05.03.04 Zanamivir Injection 
13.02.01 Zerobase ® 
13.02.01 Zerocream ® 
05.03.01 Zidovudine Retrovir®
05.03.01 Zidovudine and Lamivudine Combivir®
05.03.01 Zidovudine and lamivudine 
13.02.02 Zinc and Caster Oil Ointment BP 
13.05.02 Zinc and Salicylic Acid Paste BP 
09.05.04 Zinc Sulphate Solvazinc®
06.06.02 Zoledronic Acid 
04.01.01 Zolpidem 
04.08.01 Zonisamide Zonegran®
04.01.01 Zopiclone 
04.02.01 Zuclopenthixol Clopixol®
04.02.01 Zuclopenthixol Acetate Clopixol Acuphase®
04.02.02 Zuclopenthixol Decanoate Clopixol®
Calderdale and Huddersfield